AstraZeneca medications
The list below contains full Prescribing Information for all of our medicines, and a range of websites dedicated to providing you with product-specific information. The information contained below is intended for US residents only.
In order to monitor the safety of AstraZeneca products, we encourage reporting any side effects experienced while taking an AstraZeneca product to the AZ Information Center at 1-800-236-9933. Alternatively, you can report any side effects of prescription drugs directly to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.
Help affording your medicines
We believe it’s not enough for us to simply make medicines. We have to make sure that the people who need those medicines can get them.
ANDEXXA® Coagulation Factor Xa (recombinant), inactivated-zhzo
Prescribing Information
Consumer site
Health care professional site
BEVESPI AEROSPHERE® (glycopyrrolate and formoterol fumarate) Inhalation Aerosol
Prescribing Information
Consumer site
Health care professional site
BREZTRI AEROSPHERE® (budesonide, glycopyrrolate and formoterol fumarate) Inhalation Aerosol
Prescribing Information
Consumer site
Health care professional site
BRILINTA® (ticagrelor) tablets
Prescribing Information including Boxed WARNINGS
Consumer site
Health care professional site
BYDUREON® (exenatide extended-release) injectable suspension
Prescribing Information including Boxed WARNING
Consumer site
Health care professional site
BYDUREON BCise® (exenatide extended-release) injectable suspension
Prescribing information including Boxed WARNING
Consumer site
Health care professional site
BYETTA® (exenatide) injection
Prescribing Information
Consumer site
Health care professional site
CALQUENCE® (acalabrutinib) capsules
Prescribing information
Consumer site
Health care professional site
CRESTOR® (rosuvastatin calcium) Tablets
Prescribing Information
Consumer site
Health care professional site
DALIRESP® (roflumilast) tablets
Prescribing Information
Consumer site
Health care professional site
ENHERTU® (fam-trastuzumab deruxtecan-nxki) injection for intravenous use
Prescribing Information including Boxed WARNING
Health care professional site
EPANOVA® (omega-3-carboxylic acids) Capsules
EVUSHELD™ (tixagevimab co-packaged with cilgavimab) Pre-exposure prophylaxis of COVID-19 for emergency use only
Fact Sheet for Healthcare Providers English/Español
Fact Sheet for Patients, Parents and Caregivers English/Español
FDA Letter of Authorization
Consumer site
Health care professional site
FARXIGA® (dapagliflozin) tablets
Prescribing Information
Consumer site
Health care professional site
FASENRA® (benralizumab) injection, for subcutaneous use
Prescribing Information
Consumer site
Health care professional site
FASLODEX® (fulvestrant) injection, for intramuscular use
Prescribing Information
Consumer site
Health care professional site
FLUMIST® QUADRIVALENT (Influenza Vaccine Live, Intranasal)
Prescribing Information
Consumer site
Health care professional site
IMFINZI® (durvalumab) injection, for intravenous use
Prescribing Information
Consumer website
Health care professional website
IRESSA® (gefitinib)
Prescribing Information
Consumer site
KOMBIGLYZE® XR (saxagliptin and metformin HCl extended-release) tablets
Prescribing Information including Boxed WARNING
Consumer site
Health care professional site
LOKELMA® (sodium zirconium cyclosilicate) 10 g for oral suspension
Prescribing Information
Health care professional site
LUMOXITI® (moxetumomab pasudotox-tdfk) for injection, for intravenous use
Prescribing Information including Boxed WARNING
Consumer site
Health care professional site
LYNPARZA® (olaparib) tablets
Prescribing Information
Consumer site
Health care professional site
NEXIUM® (esomeprazole magnesium) delayed-release capsules, for oral suspension
Prescribing Information
Consumer site
Health care professional site
NEXIUM® (esomeprazole magnesium) for delayed-release oral suspension
Prescribing Information
Consumer site
Health care professional site
NEXIUM® I.V. (esomeprazole sodium) for injection, for intravenous use
ONGLYZA® (saxagliptin) tablets
Prescribing Information
Consumer site
Health care professional site
PULMICORT FLEXHALER® (budesonide inhalation powder)
Prescribing Information
Consumer site
Health care professional site
PULMICORT RESPULES® (budesonide inhalation suspension)
Prescribing Information
Consumer site
QTERN® (dapagliflozin and saxagliptin) tablets
SAPHNELO™ (anifrolumab-fnia) Injection, for intravenous use
Prescribing Information
Consumer site
Health care professional site
SEROQUEL® (quetiapine) tablets
Prescribing Information including Boxed WARNINGS
SEROQUEL XR® (quetiapine) Extended-release tablets
Prescribing Information including Boxed WARNINGS
Consumer site
Health care professional site
SYMBICORT® (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol
Prescribing Information
Consumer site
Health care professional site
SYMLIN® (pramlintide acetate) injection
Prescribing Information including Boxed WARNING
Consumer site
Health care professional site
TAGRISSO® (osimertinib) tablets
Prescribing Information
Consumer site
Health care professional site
TEZSPIRE™ (tezepelumab-ekko) Injection, for subcutaneous use
Prescribing Information
Consumer site
Health care professional site
XIGDUO® XR (dapagliflozin and metformin hydrochloride extended-release) tablets
Veeva ID: US-62564
Date of Preparation: April 2022